Down from the top - after a year and a half of leadership, Novo Nordisk lost its status as the most valuable company in Europe

The market value of Danish drug maker Novo Nordisk is falling. As a result, it lost its status as the largest company in Europe. Novo Nordisk has been overtaken by the French conglomerate LVMH in terms of market value. Bloomberg reports. Novo Nordisk's market cap fell to $355 billion. The market value of LVMH is 356...